Stock PXMD PAXMEDICA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases PaxMedica, Inc.

Equities

PXMD

US70424C2035

Market Closed - OTC Markets
Other stock markets
 03:39:29 2024-06-07 pm EDT 		5-day change 1st Jan Change
0.312 USD -2.80% Intraday chart for PaxMedica, Inc. -5.51% -58.78%
May. 13 PaxMedica, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 06 PaxMedica, Inc.(NasdaqCM:PXMD) dropped from S&P TMI Index CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101
AQ
PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy
AQ
PaxMedica's CEO and Malawi Health Official Discuss Urgent Medical Crisis in Bell2Bell Podcast
AQ
PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101
AQ
PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness
AQ
PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission
AQ
PaxMedica : Certificate of Incorporation/Bylaws - Form 8-K
PU
PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments
AQ
PaxMedica Inc. Featured in Syndicated Broadcast Highlighting FDA Type-B Meeting to Review PAX-101 Pivotal Trial Data
AQ
PaxMedica's Chief Medical Officer Discusses FDA Meeting Highlights on The Bell2Bell Podcast
AQ
PaxMedica Engages Bourne Partners to Explore Future Monetization of Potential Priority Review Voucher (PRV)
AQ
PaxMedica Acquires Suramin Research Assets from Rediscovery Life Sciences to Accelerate NDA Submission for PAX-101
GL
PaxMedica Acquires Suramin Research Assets from Rediscovery Life Sciences to Accelerate NDA Submission for PAX-101
AQ
PaxMedica Announces 1-for-17 Reverse Stock Split
GL
PaxMedica Announces 1-for-17 Reverse Stock Split
AQ
Thinking about buying stock in Nextplay Technologies, ABVC Biopharma, PaxMedica, Mustang Bio, or NXU Inc.?
PR
Penny Stock Momentum Watchlist (SING, CDIX, PXMD, ONCT)
AQ
PaxMedica's Research on Low Dose Suramin for Autism Spectrum Disorder Accepted for Publication
GL
The Bell2Bell Podcast featuring Howard Weisman, CEO and Buzz Woods of PaxMedica, Inc. (Nasdaq: PXMD)
AQ
PaxMedica Announces Gold Sponsorship of The BRAIN Foundation's Synchrony Symposia 2023
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PXMD Stock
  4. News PaxMedica, Inc.
  5. Press Releases